US Patent Issued to The Broad Institute, Biogen MA on Dec. 2 for "Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,289, issued on Dec. 2, was assigned to The Broad Institute Inc. (Cambridge, Mass.) and Biogen MA Inc. (Cambridge, Mass.).

"Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof" was invented by Florence Fevrier Wagner (Cambridge, Mass.), Michel Weiwer (Cambridge, Mass.), Arthur J. Campbell (Cambridge, Mass.), Joshua R. Sacher (Cambridge, Mass.), Edward Holson (Newton Highlands, Mass.), Brian Stuart Lucas (Arlington, Mass.) and TeYu Chen (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of Formula (I), and salts, solvates, hydrates, polymorphs, co-crystals, tautome...